MAPKAPK3
MAP kinase-activated protein kinase 3
Also known as: 3pK, MAPK3_HUMAN, MAPKAP3, MK-3, MK3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16644
- Gene
- MAPKAPK3
- Ensembl
- ENSG00000114738
- Chromosome
- 3
- Canonical length
- 382 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the Ser/Thr protein kinase family. This kinase functions as a mitogen-activated protein kinase (MAP kinase)- activated protein kinase. MAP kinases are also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This kinase was shown to be activated by growth inducers and stress stimulation of cells. In vitro studies demonstrated that ERK, p38 MAP kinase and Jun N-terminal kinase were all able to phosphorylate and activate this kinase, which suggested the role of this kinase as an integrative element of signaling in both mitogen and stress responses. This kinase was reported to interact with, phosphorylate and repress the activity of E47, which is a basic helix-loop-helix transcription factor known to be involved in the regulation of tissue-specific gene expression and cell differentiation. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
382 residues, UniProt reviewed canonical sequence.
>Q16644|MAPKAPK3
1 MDGETAEEQG GPVPPPVAPG GPGLGGAPGG RREPKKYAVT DDYQLSKQVL GLGVNGKVLE
61 CFHRRTGQKC ALKLLYDSPK ARQEVDHHWQ ASGGPHIVCI LDVYENMHHG KRCLLIIMEC
121 MEGGELFSRI QERGDQAFTE REAAEIMRDI GTAIQFLHSH NIAHRDVKPE NLLYTSKEKD
181 AVLKLTDFGF AKETTQNALQ TPCYTPYYVA PEVLGPEKYD KSCDMWSLGV IMYILLCGFP
241 PFYSNTGQAI SPGMKRRIRL GQYGFPNPEW SEVSEDAKQL IRLLLKTDPT ERLTITQFMN
301 HPWINQSMVV PQTPLHTARV LQEDKDHWDE VKEEMTSALA TMRVDYDQVK IKDLKTSNNR
361 LLNKRRKKQA GSSSASQGCN NQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAPKAPK3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 265 nTPM
Expression across tissuesHPA
Tissue
- tongue: 265 nTPM
- heart muscle: 242 nTPM
- skeletal muscle: 213 nTPM
- bone marrow: 101 nTPM
- skin: 52 nTPM
- esophagus: 49 nTPM
Single-cell type
- esophageal apical cells: 175 nCPM
- late spermatids: 170 nCPM
- hofbauer cells: 128 nCPM
- esophageal suprabasal cells: 123 nCPM
- esophageal basal cells: 87 nCPM
- megakaryocytes: 87 nCPM
Immune cell
- non-classical monocyte: 343 nTPM
- intermediate monocyte: 272 nTPM
- classical monocyte: 170 nTPM
- myeloid DC: 143 nTPM
- total PBMC: 133 nTPM
- eosinophil: 127 nTPM
Brain region
- medulla oblongata: 33 nTPM
- spinal cord: 29 nTPM
- white matter: 29 nTPM
- thalamus: 28 nTPM
- choroid plexus: 28 nTPM
- pons: 27 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAPKAPK3.
Disease | AllUniProt
Conditions MAPKAPK3 is implicated in, by any mechanism.
- Macular dystrophy, patterned, 3 (MDPT3) MIM:617111
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 320 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Patterned macular dystrophy 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.44
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular signal transduction
- macropinocytosis
- MAPK cascade
- response to cytokine
- response to lipopolysaccharide
- signal transduction
- toll-like receptor signaling pathway
- vascular endothelial growth factor receptor signaling pathway
Molecular functions
- ATP binding
- calcium-dependent protein serine/threonine kinase activity
- calcium/calmodulin-dependent protein kinase activity
- calmodulin binding
- MAP kinase kinase activity
- mitogen-activated protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAPKAPK3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAPKAPK3 as an antibody target. Whether an autoantibody or antibody against MAPKAPK3 could matter depends on whether native MAPKAPK3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAPKAPK3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAPKAPK3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...